Senator Marshall ... reiterating his call for immediate action to schedule 7-hydroxymitragynine (7-OH) and related synthetic opioid products.
Urge the DEA to immediately schedule 7-hydroxymitragynine (7-OH) and related synthetic opioid products as controlled substances.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
On January 13, 2026, Senator Roger Marshall sent a follow-up letter to the DEA, reiterating his call for immediate action to schedule 7-hydroxymitragynine (7-OH) and related synthetic opioid products.
legacy_unverified · Source version not recorded · locator unknown
On October 28, 2025, Senator Marshall sent a letter to DEA Administrator Terrence Cole, urging the agency to take action and emergency schedule 7-hydroxymitragynine (7-OH) and related products as Schedule I controlled substances.
legacy_unverified · Source version not recorded · locator unknown
On December 3, 2025, Senator Marshall issued a statement applauding the federal seizure of approximately 73,000 units of 7-OH products at three warehouses in the Kansas City region.
legacy_unverified · Source version not recorded · locator unknown
On December 2, 2025, the Justice Department, together with the FDA, announced the seizure of approximately 73,000 units of 7-hydroxymitragynine (7-OH) products at three warehouses.
legacy_unverified · Source version not recorded · locator unknown
On October 24, 2025, Senator Marshall toured the Clinical Reference Laboratory to raise awareness about the growing threat of 7-hydroxymitragynine (7-OH), a powerful, unregulated opioid compound derived from the kratom plant.
Assessments
Marshall sent multiple letters to the DEA in 2025 and 2026 explicitly urging immediate/emergency scheduling of 7-hydroxymitragynine (7-OH) and related products. That satisfies the promised action itself, even though the records provided do not show the DEA actually scheduling the substances.
Senator Roger Marshall made repeated and serious efforts to urge the DEA to schedule 7-hydroxymitragynine (7-OH) and related synthetic opioids as controlled substances. This included sending multiple letters to the DEA, public advocacy, and raising awareness. However, there is no evidence that the DEA actually scheduled 7-OH or related products in response. Federal seizures of 7-OH products occurred, but this does not equate to their formal scheduling. Therefore, while the promise itself (to urge the DEA) was actioned by the Senator, the intended outcome (DEA scheduling 7-OH) was not delivered, despite substantial effort.